Abstract
Background
Interleukin-22 (IL22) has been implicated in inflammation and tumorigenesis. The association between IL22 gene polymorphisms and cancer risk has been widely explored. However, the limited sample sizes of previous studies may produce inadequate statistical power and conflicting results, which calls for further investigations. In this study, we recruited a total of 1490 cancer patients (480 liver cancer patients, 550 lung cancer patients, and 460 gastric cancer patients) and 800 normal controls to explore the associations between IL22 gene polymorphisms (rs1179251, rs2227485, rs2227511, and rs2227473) and cancer risk.
Method
The genotyping was performed with polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) and Sanger sequencing.
Results
Our results showed that none of the four IL22 gene polymorphisms was associated with the risk of liver, lung or gastric cancer in Hubei Han Chinese population. To improve the statistical strength, a meta-analysis was further conducted. The results further confirmed our present findings and showed that rs1179251, rs2227485, and rs2227473 were not associated with cancer risk in total or stratified analysis.
Conclusion
Consequently, the rs1179251, rs2227485, rs2227511, and rs2227473 polymorphisms may not be associated with cancer risk. However, further investigations using larger samples in different ethnic populations are required.
Similar content being viewed by others
References
Lim C, Savan R (2014) The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev 25(3):257–271. https://doi.org/10.1016/j.cytogfr.2014.04.005
Wolk K, Sabat R (2006) Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17(5):367–380. https://doi.org/10.1016/j.cytogfr.2006.09.001
Sabat R, Ouyang W, Wolk K (2014) Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov 13(1):21–38. https://doi.org/10.1038/nrd4176
Wolk K, Witte E, Witte K et al (2010) Biology of interleukin-22. Semin Immunopathol 32(1):17–31. https://doi.org/10.1007/s00281-009-0188-x
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
Zhang M, Tuo J, Li GC (2013) Wei SZ (2018) Cancer incidence and mortality in Hubei cancer registries. Cancer Res Prev Treat 45(06):414–419. https://doi.org/10.3971/j.issn.1000-8578.2018.17.1200
Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nat Rev Genet 2(2):91–99. https://doi.org/10.1038/35052543
Shastry BS (2009) SNPs: impact on gene function and phenotype. Methods Mol Biol 578:3–22. https://doi.org/10.1007/978-1-60327-411-1_1
Qin SY, Yang XW, Luo W et al (2015) Association of interleukin 22 polymorphisms with gastric cancer risk. Tumour Biol 36(3):2033–2039. https://doi.org/10.1007/s13277-014-2810-3
He X, Wang XH, Qiu ZG et al (2013) A study on the correlation between single nucleotide polymorphism (SNP) of IL-22 gene and susceptibility to HCC. J Gannan Med Univ 33(1):29–32
Wang YM, Li ZX, Tang FB et al (2016) Association of genetic polymorphisms of interleukins with gastric cancer and precancerous gastric lesions in a high-risk Chinese population. Tumour Biol 37(2):2233–2242. https://doi.org/10.1007/s13277-015-4022-x
Thompson CL, Plummer SJ, Tucker TC et al (2010) Interleukin-22 genetic polymorphisms and risk of colon cancer. Cancer Causes Control 21(8):1165–1170. https://doi.org/10.1007/s10552-010-9542-5
Mohebbi SR, Karimi K, Rostami F et al (2014) Association of interleukin-22 gene polymorphism (rs1179251) and colorectal cancer risk in the Iranian population. Indian J Virol 22(1):29–36. https://doi.org/10.1007/s13337-011-0029-0
Zhao T, Wu X, Liu J (2015) Association between interleukin-22 genetic polymorphisms and bladder cancer risk. Clinics (Sao Paulo) 70(10):686–690. https://doi.org/10.6061/clinics/2015(10)05
Liao F, Hsu YC, Kuo SH et al (2014) Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma. Blood Cancer J 4:e20. https://doi.org/10.1038/bcj.2014.70
Eun YG, Shin IH, Lee YC et al (2013) Interleukin 22 polymorphisms and papillary thyroid cancer. J Endocrinol Invest 36(8):584–587. https://doi.org/10.3275/8879
Zhang G, Chen X, Chan L et al (2011) An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese. Sci Rep 1:20. https://doi.org/10.1038/srep00020
Munafò MR, Flint J (2004) Meta-analysis of genetic association studies. Trends Genet 20(9):439–444. https://doi.org/10.1016/j.tig.2004.06.014
Chen BF, Yi C, Wang JD et al (2019) A comprehensive study of CD44 rs 187115 variant and cancer risk in a central Chinese population. J Cell Biochem 120(8):12949–12957. https://doi.org/10.1002/jcb.28566
Sedgwick P (2012) Multiple significance tests: the Bonferroni correction. BMJ 344:e509. https://doi.org/10.1136/bmj.e509
Hayashino Y, Noguchi Y, Fukui T (2005) Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol 15(6):235–243
Cargill M, Altshuler D, Ireland J et al (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22(3):231–238. https://doi.org/10.1038/10290
Lek M, Karczewski KJ, Minikel EV et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285–291. https://doi.org/10.1038/nature19057
Zeng Y, Wang G, Yang E et al (2015) Aberrant gene expression in humans. PLoS Genet 11(1):e1004942. https://doi.org/10.1371/journal.pgen.1004942
Zhang J, Zhao T, Xu C et al (2018) Four polymorphisms in the IL-22 gene and the risk of cancer: a meta-analysis. J Evid Based Med 11(2):101–104. https://doi.org/10.1111/jebm.12296
Lin L, Xu W, Zhang G et al (2017) Association of interleukin-22 polymorphisms with the colon cancer: a case-control study. Immunol Lett 188:59–63. https://doi.org/10.1016/j.imlet.2017.06.007
Hamed A, Gholamreza A, Ahmad J et al (2018) Atorvastatin, losartan and captopril may upregulate IL-22 in hypertension and coronary artery disease. Life Sci 207:525–531. https://doi.org/10.1016/j.lfs.2018.07.005
Ding GG, Zhang GL, Chen XC et al (2012) A study on the relationship between single nucleotide polymorphisms of interleukin-22 and susceptibility to pulmonary tuberculosis. Chin J Tuberc Respir Dis 35(8):596–600
Funding
This work was supported by grants from the National Natural Science Foundation of China (81502427), the Natural Science Foundation of Hubei Province (2019CFB756), and the Fundamental Research Funds for the Central Universities (WUT: 2018IB023, 2019IB005 and 2019-HS-B1-13).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Wang, H., Huang, C., Liu, Y. et al. Lack of association between interleukin-22 gene polymorphisms and cancer risk: a case–control study and a meta-analysis. Int J Clin Oncol 25, 521–530 (2020). https://doi.org/10.1007/s10147-019-01595-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-019-01595-8